Carmen de Mendoza

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

Drug design, development and therapy

GigaByte (Hong Kong, China)

Journal of medical virology

Mediators of inflammation

Universidad Complutense de Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Universidad Complutense de Madrid - Jun 07 2000

Spain

PHD

Universidad Complutense de Madrid - Jul 25 1996

Spain

BSC

Publications

Renato Santos, Víctor Moreno-Torres, Ilduara Pintos-Pascual, Octavio Corral, Carmen de Mendoza, Vicente Soriano, Manuel Corpas
Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients. GigaByte (Hong Kong, China) 2024 (2024)
Renato Santos, Víctor Moreno-Torres, Ilduara Pintos-Pascual, Octavio Corral, Carmen de Mendoza, Vicente Soriano, Manuel Corpas
Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients. GigaByte (Hong Kong, China) 2024 (2024)
Carmen de Mendoza, Paula Carrizo, Silvia Sauleda, Alberto Richart, Ariadna Rando, Elisenda Miró, Rafael Benito, Oscar Ayerdi, Begoña Encinas, Antonio Aguilera, Gabriel Reina, Silvia Rojo, Rocío González, Mario Fernández-Ruiz, Paloma Liendo, Natalia Montiel, Lourdes Roc, Ana Treviño, María José Pozuelo, Vicente Soriano, null null
The slowdown of new infections by human retroviruses has reached a plateau in Spain. Journal of medical virology 95 (5) (2023)
Vicente Soriano, Victor Moreno-Torres, Ana Treviño, Octavio Corral, Carmen de Mendoza
Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy. Drug design, development and therapy 17 (2023)
Vicente Soriano, Victor Moreno-Torres, Ana Treviño, Octavio Corral, Carmen de Mendoza
Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy. Drug design, development and therapy 17 (2023)
Vicente Soriano, Victor Moreno-Torres, Ana Treviño, Octavio Corral, Carmen de Mendoza
Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy. Drug design, development and therapy 17 (2023)
José-Manuel Ramos-Rincon, Héctor Pinargote-Celorio, Carmen de Mendoza, Clara Ramos-Belinchón, Pablo Barreiro, Félix Gómez-Gallego, Octavio Corral, Vicente Soriano
Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies. Journal of viral hepatitis 29 (9) (2022)
Maria Martinez-Urbistondo, Alberto Mora-Vargas, Esther Expósito-Palomo, Raquel Castejón, María-Jesús Citores, Silvia Rosado, Carmen de Mendoza, Isolina Baños, Ana Fernández Cruz, Lidia Daimiel Ruiz, Rodrigo San-Cristóbal, Juan-Antonio Vargas-Núñez, José Alfredo Martínez Hernández
Inflammatory-Related Clinical and Metabolic Outcomes in COVID-19 Patients. Mediators of inflammation 2020 (2020)
Itzíar Carrasco, Ana Arias, Laura Benítez-Gutiérrez, Gemma Lledó, Silvia Requena, Miriam Cuesta, Valentín Cuervas-Mons, Carmen de Mendoza
Baseline NS5A resistance associated substitutions may impair DAA response in real-world hepatitis C patients. Journal of medical virology 90 (3) (2017)

Carmen de Mendoza.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Carmen de Mendoza